Clinical Study
Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
Table 2
Tumor characteristics of the complete series.
| | Histology | | | | Endometrioid | 3 971 | 87.4% | | Nonendometrioid | 323 | 7.1% | | Unspecified | 249 | 5.5% |
| | Nuclear grade | | | | 1 | 538 | 11.8% | | 2 | 746 | 16.4% | | 3 | 433 | 9.5% | | Unknown | 2 866 | 62.2% |
| | P53 status | | | | Positive | 249 | 5.5% | | Negative | 258 | 5.7% | | Unknown | 4 036 | 88.8% |
| | Myometrial infiltration | | | | Endometrium alone | 95 | 2.1% | | ≤50% | 1 562 | 34.4% | | >50% | 848 | 18.7% | | Unknown | 2 038 | 44.9% |
| | FIGO grade | | | | 1 | 1 433 | 31.5% | | 2 | 1 808 | 39.8% | | 3 | 850 | 18.7% | | Unknown | 452 | 9.9% |
| | DNA ploidy | | | | Diploid | 1 231 | 27.1% | | Nondiploid | 382 | 8.4% | | Unknown | 2 930 | 64.5% |
|
|
